Calithera Biosciences (NASDAQ:CALA) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Trading Down 90.0 %

Shares of NASDAQ:CALA opened at $0.00 on Thursday. Calithera Biosciences has a 52-week low of $0.00 and a 52-week high of $0.12.

Calithera Biosciences Company Profile

(Get Free Report)

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.

Read More

• Five stocks we like better than Calithera Biosciences
• How to Invest in Small Cap Stocks 
• S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
• With Risk Tolerance, One Size Does Not Fit All
• How AI Implementation Could Help MongoDB Roar Back in 2025
• Buy P&G Now, Before It Sets A New All-Time High
• Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?